Akero Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Akero Therapeutics, Inc. reported Earnings Per Share, Basic and Diluted of -$0.74 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-06
- Akero Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.74.
- Akero Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.70.
- Akero Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.83.
- Akero Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.43.
- Akero Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2021 was -$2.89.
- Akero Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$2.52.
- Akero Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$2.90.
- Akero Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$795.28.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.74 10-Q · filed 2022-05-06 | |||
| 2021-12-31 | -$2.89 10-K · filed 2022-02-25 | |||
| 2021-09-30 | -$0.70 10-Q · filed 2021-11-12 | -$1.96 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | -$0.83 10-Q · filed 2021-08-13 | -$1.27 10-Q · filed 2021-08-13 | ||
| 2021-03-31 | -$0.43 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | -$2.52 10-K · filed 2022-02-25 | |||
| 2020-09-30 | -$0.63 10-Q · filed 2021-11-12 | -$1.63 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$0.57 10-Q · filed 2021-08-13 | -$0.98 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$0.42 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$0.55 derived: net income ÷ weighted average shares · filed 2022-02-25 | -$1.10 derived: net income ÷ weighted average shares · filed 2022-02-25 | -$1.93 derived: net income ÷ weighted average shares · filed 2022-02-25 | -$2.90 10-K · filed 2022-02-25 |
| 2019-09-30 | -$0.56 10-Q · filed 2020-11-12 | -$1.46 derived: net income ÷ weighted average shares · filed 2020-11-12 | -$2.66 10-Q · filed 2020-11-12 | -$11.36 derived: net income ÷ weighted average shares · filed 2020-11-12 |
| 2019-06-30 | -$2.21 10-Q · filed 2020-08-12 | -$7.29 10-Q · filed 2020-08-12 | -$62.07 derived: net income ÷ weighted average shares · filed 2020-08-12 | -$92.19 derived: net income ÷ weighted average shares · filed 2020-08-12 |
| 2019-03-31 | -$31.90 10-Q · filed 2020-05-13 | -$417.61 derived: net income ÷ weighted average shares · filed 2020-05-13 | -$525.01 derived: net income ÷ weighted average shares · filed 2020-05-13 | -$645.33 derived: net income ÷ weighted average shares · filed 2020-05-13 |
| 2018-12-31 | -$403.18 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$521.74 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$659.30 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$795.28 10-K · filed 2020-03-16 |
| 2018-09-30 | -$89.66 10-Q · filed 2019-11-12 | -$183.68 derived: net income ÷ weighted average shares · filed 2019-11-12 | -$236.67 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$94.86 10-Q · filed 2019-08-12 | -$137.97 10-Q · filed 2019-08-12 |